Sarah Zielsdorf, MD, MS - Rheumatoid Arthritis (2018 Conference) (LDN, low dose naltrexone)
Dr Sarah Zielsdorf shares her presentation on Rheumatoid Arthritis (RA) at The LDN 2018 Conference.
In this presentation Dr Zielsdorf presents a fascinating case study of a patient with Rheumatoid Arthritis (RA) detailing her experience with symptoms, statistics and her own wealth of medical experience.
Dr Zielsdorf also thoroughly analyses the typical causes of RA and analyses the historical, scientific perspective that RA has been viewed from. Several theories for the origin of RA are proposed, one of which includes dysbiosis drivers.
Methotrexate (MTX) is a drug which is also mentioned. Dr Zielsdorf expertly breaks down the drug’s mechanism of action within the body, explaining its effects including the inhibition of T-cell activation.
This is a summary of Dr Sarah Zielsdorf’s presentation. Please listen to the rest of Dr Zielsdorf’s presentation by clicking on the video above.